Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
128 participants
INTERVENTIONAL
2025-11-04
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants will be randomized into one of two groups: Group A: ACT Lung Health Intervention versus Group B: Standard Care. Randomization means a participant is placed into a study group by chance.
The research study procedures include screening for eligibility, questionnaires, and saliva tests.
It is expected participation in this study will last about 6 months.
About 60 participants are expected to take part in this research study.
The National Cancer Institute is providing funding for this trial.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A: ACT Lung Health Intervention
Participants will be randomized 1:1 by block size and stratified by ethnicity and readiness to quit smoking and will complete:
* Baseline visit
* Questionnaires at 1, 3, and 6 months
* 3 month saliva test
* Weekly Zoom sessions
* 6 month saliva test
ACT Lung Health Intervention
An Asian culture-tailored lung health intervention, which includes individual counseling sessions, family coaching, provision of nicotine replacement therapy (NRT) in the form of patches, lozenges, or chewing gum, and educational materials about low-dose computed tomography (LDCT) for lung cancer screening. The eight weekly, counseling sessions with study staff will be conducted via phone call or the Zoom web-conferencing platform.
Group B: Standard Care
Participants will be randomized 1:1 by block size and stratified by ethnicity and readiness to quit smoking and will complete:
* Baseline visit
* Questionnaires at 1, 3, and 6 months
* 3 month saliva test
* Weekly Zoom sessions
* 6 month saliva test
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ACT Lung Health Intervention
An Asian culture-tailored lung health intervention, which includes individual counseling sessions, family coaching, provision of nicotine replacement therapy (NRT) in the form of patches, lozenges, or chewing gum, and educational materials about low-dose computed tomography (LDCT) for lung cancer screening. The eight weekly, counseling sessions with study staff will be conducted via phone call or the Zoom web-conferencing platform.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Speak either Korean, Mandarin, or English
* Eligible for LDCT screening (50-80 years of age and 20- pack-year smoking history)
* Currently smoking (i.e., having smoked within the prior 30 days),
* Currently have active health insurance coverage and a primary healthcare provider and
* Have access to a video-call device with internet or wireless connection.
* Eastern Cooperative Oncology Group functional status \<2
* Live in the United States for the next 12 months
Exclusion Criteria
* Hospitalization due to a serious mental illness (e.g., psychotic disorders) during the prior 6 months.
* Previous history of lung cancer.
* We will not include any of the following special populations:
* Adults unable to consent.
* Adults younger than 50 or older than 80 years
* Individuals who are not yet adults (infants, children, teenagers)
* Pregnant women
* Prisoners
50 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
University of Massachusetts, Boston
OTHER
Dana-Farber Cancer Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mary E. Cooley, Phd
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mary Cooley, PhD
Role: PRINCIPAL_INVESTIGATOR
Dana-Farber Cancer Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Mary Cooley, PhD
Role: primary
Mary Cooley, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.